Mochida Pharmaceutical Co., Ltd. (TYO:4534)
Japan flag Japan · Delayed Price · Currency is JPY
3,355.00
+5.00 (0.15%)
Nov 13, 2026, 3:30 PM JST

Mochida Pharmaceutical Cash Flow Statement

Millions JPY. Fiscal year is Apr - Mar.

Operating Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Net Income
15,13311,1718,0526,1609,04414,591
Depreciation & Amortization
3,4392,9792,9402,8082,6722,689
Loss (Gain) From Sale of Assets
2114-2253112
Loss (Gain) From Sale of Investments
-96072--100--526
Loss (Gain) on Equity Investments
-1,559-793618168--
Other Operating Activities
-3,709-2,255-951-1,366-4,172-5,709
Change in Accounts Receivable
-5,901-4,8593,220-7,0323,869-2,486
Change in Inventory
-4,021-2,825-3,016-5,873-1,277-521
Change in Accounts Payable
1,9172,116-3,5222,225-1,9412,176
Change in Other Net Operating Assets
-16,589-12,9571,999-4,448-951-2,867
Operating Cash Flow
-12,248-7,3509,354-7,4807,2977,459
Operating Cash Flow Growth
-----2.17%-18.91%

Investing Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Capital Expenditures
-2,194-2,695-2,160-2,296-2,166-2,988
Sale of Property, Plant & Equipment
--256--
Investment in Securities
-15,765-14,16019,5002,301-1,1001,098
Other Investing Activities
-271313317-117
Investing Cash Flow
-17,961-16,84817,35574-2,949-2,007

Financing Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Long-Term Debt Issued
-10,000----
Net Debt Issued (Repaid)
10,00010,000----
Repurchase of Common Stock
-1,060-2-3-3,492-3,512-2,511
Common Dividends Paid
-2,835-2,835-2,835-2,887-3,372-3,445
Other Financing Activities
-132-130-27-14--
Financing Cash Flow
5,9737,033-2,865-6,393-6,884-5,956

Net Cash Flow

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Foreign Exchange Rate Adjustments
937316793231
Miscellaneous Cash Flow Adjustments
1----1
Net Cash Flow
-24,142-17,09223,860-13,720-2,504-472

Free Cash Flow

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Free Cash Flow
-14,442-10,0457,194-9,7765,1314,471
Free Cash Flow Growth
----14.76%-38.44%
Free Cash Flow Margin
-11.43%-8.59%6.84%-9.50%4.97%4.06%
Free Cash Flow Per Share
-408.25-283.36202.93-272.59138.08117.34
Levered Free Cash Flow
-27-10,0326,041-10,0505,8905,615
Unlevered Free Cash Flow
75.5-9,9876,042-10,0495,8905,615

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash Interest Paid
1788718373536
Cash Income Tax Paid
3,8072,3539481,3683,2243,616
Change in Working Capital
-24,594-18,525-1,319-15,128-300-3,698